Dr. Dennis Edwards Daniels, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1906a Greenwood Dr, Poplar Bluff, MO 63901 Phone: 573-778-5913 Fax: 573-776-7750 |
News Archive
A more aggressive approach to treating acne that marries the disciplines of psychology and dermatology is needed, according to two UC Riverside psychology researchers.
Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration for its Articulating HD 3D Laparoscopic Surgical Video System.
An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease.
Hospira, Inc.,, the world leader in generic injectable pharmaceuticals, and Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, today announced that the Hart-Scott-Rodino (HSR) review period for Hospira's proposed acquisition of Orchid's generic injectable pharmaceuticals business has expired with no action by the Federal Trade Commission (FTC).
Opexa Therapeutics, Inc., a company developing a novel T-cell therapy for multiple sclerosis (MS), announced today that the Company has been selected to present key efficacy data at the upcoming American Academy of Neurology (AAN) 62nd Annual Meeting to be held in Toronto, Canada.
› Verified 9 days ago